July 9, 2025 · Form 4 insider transaction
Cramer Pamela J. sold 3,516 shares of Rhythm Pharmaceuticals, Inc. at $80.00 per share, a transaction worth $281.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.